Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this live, virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.

Send Email 1.888.257.6457

Back to Agenda

Regulatory Affairs: Part 2: IND Amendments

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

Kevin Daniel Healy, PhD

Senior Vice President Regulatory Affairs

Entrada Therapeutics, United States

Regulatory Affairs: Part 2: IND Amendments

Have an account?

Regulatory Affairs: The IND, NDA, and Post-Marketing

Regulatory Affairs: Part 2: IND Amendments

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

Kevin Daniel Healy, PhD

Be informed and stay engaged.